Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

India Reschedules Drug Export Track And Trace Plan

This article was originally published in SRA

Executive Summary

India has deferred the implementation of its track and trace system for pharmaceutical exports - measures that are essentially aimed at curbing the menace of fake products and also enhance supply-chain safety1.

Advertisement

Related Content

India’s E-Plan To Map Drug Sales – Turning Point For Better Traceability?
Advertisement
UsernamePublicRestriction

Register

PS118526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel